# Contrast Enhanced Endoscopic Ultrasound for Vascular Involvement in Pancreatic Lesions

> **NCT01526590** · NA · WITHDRAWN · sponsor: **University of Vermont**

## Conditions studied

- Pancreatic Tumors

## Interventions

- **DRUG:** Definity Contrast

## Key facts

- **NCT ID:** NCT01526590
- **Lead sponsor:** University of Vermont
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-07
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of support
- **Last updated:** 2015-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01526590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01526590, "Contrast Enhanced Endoscopic Ultrasound for Vascular Involvement in Pancreatic Lesions". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT01526590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*